Skip to main content

Table 3 Clinical and molecular characteristics of 2 primary pediatric T-ALL

From: BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes

Case

Gender

Age (y)

Karyotype comments

Fusion Gene

Mutation

Initial BM blast (%)

WBC (× 109/L)

D15th BM blast (%)

D33th BM blast (%)

1

Male

3.75

88–92,XY, + X, + Y, + 1 × 2, + 2 × 2, + 3 × 2, + 4 × 2, + 5 × 2, + 6 × 2, + 7 × 2, + 8 × 2, + 9 × 2 + ……. + 22 × 2

PICALM/MLLT10

None

88

122.82

92

47

2

Female

10.25

46,XX,t (10,11) (p13,q23), add (15) (q25)/46,idem, + mar

DDX3X/MLLT10

NOTCH1 (41.2%),NRAS (80.7%)

89

35.33

82

21